JP2025084921A5 - - Google Patents

Info

Publication number
JP2025084921A5
JP2025084921A5 JP2025032538A JP2025032538A JP2025084921A5 JP 2025084921 A5 JP2025084921 A5 JP 2025084921A5 JP 2025032538 A JP2025032538 A JP 2025032538A JP 2025032538 A JP2025032538 A JP 2025032538A JP 2025084921 A5 JP2025084921 A5 JP 2025084921A5
Authority
JP
Japan
Prior art keywords
aqueous composition
composition according
phosphate
aqueous
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025032538A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025084921A (ja
Filing date
Publication date
Priority claimed from JP2019168569A external-priority patent/JP6886502B2/ja
Application filed filed Critical
Publication of JP2025084921A publication Critical patent/JP2025084921A/ja
Priority to JP2025153045A priority Critical patent/JP2025176149A/ja
Publication of JP2025084921A5 publication Critical patent/JP2025084921A5/ja
Pending legal-status Critical Current

Links

JP2025032538A 2016-05-25 2025-03-03 アトロピン含有水性組成物 Pending JP2025084921A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025153045A JP2025176149A (ja) 2016-05-25 2025-09-16 アトロピン含有水性組成物

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SG10201604200P 2016-05-25
SG10201604200P 2016-05-25
JP2019168569A JP6886502B2 (ja) 2016-05-25 2019-09-17 アトロピン含有水性組成物
JP2021082578A JP7224390B2 (ja) 2016-05-25 2021-05-14 アトロピン含有水性組成物
JP2023016850A JP2023058574A (ja) 2016-05-25 2023-02-07 アトロピン含有水性組成物

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2023016850A Division JP2023058574A (ja) 2016-05-25 2023-02-07 アトロピン含有水性組成物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025153045A Division JP2025176149A (ja) 2016-05-25 2025-09-16 アトロピン含有水性組成物

Publications (2)

Publication Number Publication Date
JP2025084921A JP2025084921A (ja) 2025-06-03
JP2025084921A5 true JP2025084921A5 (https=) 2026-01-28

Family

ID=60411416

Family Applications (6)

Application Number Title Priority Date Filing Date
JP2017102939A Active JP6590860B2 (ja) 2016-05-25 2017-05-24 アトロピン含有水性組成物
JP2019168569A Active JP6886502B2 (ja) 2016-05-25 2019-09-17 アトロピン含有水性組成物
JP2021082578A Active JP7224390B2 (ja) 2016-05-25 2021-05-14 アトロピン含有水性組成物
JP2023016850A Withdrawn JP2023058574A (ja) 2016-05-25 2023-02-07 アトロピン含有水性組成物
JP2025032538A Pending JP2025084921A (ja) 2016-05-25 2025-03-03 アトロピン含有水性組成物
JP2025153045A Pending JP2025176149A (ja) 2016-05-25 2025-09-16 アトロピン含有水性組成物

Family Applications Before (4)

Application Number Title Priority Date Filing Date
JP2017102939A Active JP6590860B2 (ja) 2016-05-25 2017-05-24 アトロピン含有水性組成物
JP2019168569A Active JP6886502B2 (ja) 2016-05-25 2019-09-17 アトロピン含有水性組成物
JP2021082578A Active JP7224390B2 (ja) 2016-05-25 2021-05-14 アトロピン含有水性組成物
JP2023016850A Withdrawn JP2023058574A (ja) 2016-05-25 2023-02-07 アトロピン含有水性組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025153045A Pending JP2025176149A (ja) 2016-05-25 2025-09-16 アトロピン含有水性組成物

Country Status (15)

Country Link
US (2) US20210267885A1 (https=)
EP (2) EP4112055A1 (https=)
JP (6) JP6590860B2 (https=)
KR (4) KR102580933B1 (https=)
CN (3) CN117205209A (https=)
AR (1) AR108591A1 (https=)
CA (1) CA3023149C (https=)
EA (1) EA201892703A1 (https=)
ES (1) ES2929368T3 (https=)
MY (1) MY189774A (https=)
PH (1) PH12018502421A1 (https=)
SG (1) SG11201809822SA (https=)
TW (3) TWI874894B (https=)
UA (1) UA126195C2 (https=)
WO (1) WO2017204262A1 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
WO2016172712A2 (en) * 2015-04-23 2016-10-27 Sydnexis, Inc. Ophthalmic composition
EP3302426A4 (en) 2015-05-29 2018-12-05 Sydnexis, Inc. D2o stabilized pharmaceutical formulations
PH12019501945B1 (en) * 2017-02-21 2024-02-21 Singapore Health Serv Pte Ltd Composition and method for preventing or delaying onset of myopia comprising atropine
US10251875B2 (en) 2017-05-11 2019-04-09 Nevakar Inc. Atropine pharmaceutical compositions
CN110934869B (zh) * 2018-09-25 2023-07-04 沈阳兴齐眼药股份有限公司 一种阿托品药物组合物和药盒产品
CN114533652B (zh) * 2018-09-25 2024-12-13 沈阳兴齐眼药股份有限公司 药物组合物、其制备方法和用途
PT3701938T (pt) 2019-03-01 2024-01-31 Medivis S R L Formulações oftálmicas à base de atropina
CN114302726A (zh) 2020-08-04 2022-04-08 参天制药株式会社 用于治疗近视、预防近视及/或抑制近视发展的药剂
WO2022080397A1 (ja) * 2020-10-14 2022-04-21 参天製薬株式会社 安定な医薬組成物
WO2022094409A1 (en) 2020-11-02 2022-05-05 Trethera Corporation Crystalline forms of a deoxycytidine kinase inhibitor and uses thereof
WO2022130337A1 (en) * 2020-12-17 2022-06-23 Sun Pharmaceutical Industries Limited An aqueous sterile solution of atropine for ophthalmic use
EP4088714A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
EP4088713A1 (en) 2021-05-10 2022-11-16 Warszawskie Zaklady Farmaceutyczne Polfa S.A. Ophthalmic pharmaceutical composition comprising atropine
US20230120997A1 (en) * 2021-10-18 2023-04-20 Ocular Science, Inc. Compositions and methods for myopia control and orthokeratology lenses treatment
CN114129511A (zh) * 2021-12-07 2022-03-04 河南润弘制药股份有限公司 一种具有改进稳定性的硫酸阿托品注射液
US12527739B2 (en) * 2022-09-11 2026-01-20 Alcon Inc. Aqueous pharmaceutical compositions comprising benzyl atropine and uses thereof
JP7665073B1 (ja) 2024-04-05 2025-04-18 ロート製薬株式会社 容器に収容してなる眼科用組成物
JP7723851B1 (ja) * 2024-11-22 2025-08-14 参天製薬株式会社 アトロピン含有水性医薬組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2617508B2 (ja) * 1988-02-05 1997-06-04 エーザイ株式会社 安定なジフェンヒドラミン含有水溶液
JP3166002B2 (ja) * 1997-01-27 2001-05-14 日本車輌製造株式会社 自動車の洗浄装置
US20030096831A1 (en) 2000-01-18 2003-05-22 Stone Richard A. Ocular growth and nicotinic antagonists
EP1397132A4 (en) * 2001-05-25 2006-12-13 Valley Forge Pharmaceuticals I OPHTHALMIC PIRENZEPINE GEL
US20070254914A1 (en) * 2006-05-01 2007-11-01 Non-Profit Organization Chang Gung Memorial Hospital Low-concentration atropine solution for preventing myopia progression and preparing method thereof
JP2007308398A (ja) * 2006-05-17 2007-11-29 Chang Gung Memorial Hospital 目薬、及びその製造方法
EP2152255A1 (en) * 2007-05-21 2010-02-17 Neuroptix Corporation Ophthalmic formulations of amyloid- contrast agents and methods of use thereof
CN101327216A (zh) * 2007-06-22 2008-12-24 肖正连 一种硫酸阿托品眼用即型凝胶
WO2012161655A1 (en) 2011-05-23 2012-11-29 Singapore Health Services Pte Ltd Composition and/or method for reducing and/or preventing myopia progression comprising atropine
US20160009705A1 (en) * 2014-06-24 2016-01-14 Sydnexis, Inc. Ophthalmic composition
US9421199B2 (en) * 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
JP2017102939A (ja) * 2016-12-26 2017-06-08 株式会社プロフィールド オーサリング装置、オーサリング方法、およびプログラム
US10251875B2 (en) 2017-05-11 2019-04-09 Nevakar Inc. Atropine pharmaceutical compositions

Similar Documents

Publication Publication Date Title
JP2025084921A5 (https=)
JP2020007356A5 (https=)
JP2022062045A5 (https=)
JP2013525501A5 (https=)
RU2013132210A (ru) Новая фармацевтическая композиция, включающая нпвс и циклодекстрин
JP2018021007A5 (https=)
RU2008112146A (ru) Композиции и способы получения слаборастворимых в воде лекарственных средств с увеличенной стабильностью
RU2009136580A (ru) Производство быстрорастворимых/распадающихся пленок, содержащих большое количество активных веществ
JP2007500244A5 (https=)
KR920014467A (ko) 경구용 글리코스아미노글리칸을 함유하는 제약학적 조성물
JP2002519331A (ja) 等張性塩水溶液の使用、同調製方法及び前記溶液をベースとする医薬
JP2021513558A5 (https=)
Hess The role of Tamm-Horsfall glycoprotein and nephrocalcin in calcium oxalate monohydrate crystallization processes
NL9400160A (nl) Therapeutische samenstelling voor het vervangen en/of aanvullen van lichaamsvloeistoffen.
JP2021191802A5 (https=)
JP2009519935A5 (https=)
JP2024512121A5 (https=)
AR058323A1 (es) Formulacion de suspension de fexofenadina
JPWO2021246388A5 (https=)
JP2010518075A5 (https=)
JPH07508532A (ja) 活性物質の制御された放出のための組成物ならびにそのような組成物の調製方法
JP4956981B2 (ja) オキシメタゾリン含有水性組成物
JP2005047929A5 (https=)
RU2007103195A (ru) Пероральная композиция тедисамила с замедленным высвобождением, обладающая свойством задержки в желудке
JP2009519313A5 (https=)